DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Blay JY, Le Cesne A, Ray-Coquard I. et al.
Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumours comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.
J Clin Oncol 2007; 25: 1107-1113
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.